|Podcasts|February 7, 2023
The Rewarding Path Of Science
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Dr. Sean Bohen, CEO of Olema Oncology, discusses his career and significant contributions to the clinical research and development of numerous oncology drugs that received regulatory approval for various indications. Plus a look at Olema, how they operate, and challenges they face.
Related Content
Trending on Applied Clinical Trials Online
1
The Handoff Illusion: Why Clean Transitions in Clinical Development Are a Myth
2
ACT Brief: Inspection Readiness Throughout Lifecycle, AI Churn and Operational Discipline, and Global Trial Stakeholder Alignment
3
ACT Brief: Data Readiness Gap in Continuous Monitoring, Workflow-Centric AI Deployment, and First-in-Class ADHD Mechanism
4
Beyond Compliance: YPrime's Paulo Limgenco on Moving ESG From Reporting to Real Business Value
5